August 29 – 31, 2023 | Berlin, Germany

Built with biopharmaceutical industry insights, this in-person conference will delve into novel analytical and biological assays for optimized purity, safety, and efficacy to overcome the challenges of consistent and stable analytical testing and producing scalable and cost-effective techniques for rapid development, approval and commercialization of safe and efficacious mRNA-based therapeutics and vaccines.

View our seminar, “Utilizing eRibo to Interrogate Ribosome-RNA Associations” on August 30 by Eclipsebio’s CEO & Co-Founder, Peter Chu, PhD.